Phathom Pharmaceuticals (PHAT) PT Lowered to $22 at Guggenheim
Tweet Send to a Friend
(Updated - July 30, 2026 1:04 PM EDT)
Guggehneim analyst Yatin Suneja lowered the price target on Phathom Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggehneim analyst Yatin Suneja lowered the price target on Phathom Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


